PCM
ARLZ

PAR Capital Management’s Aralez Pharmaceuticals Inc. ARLZ Stock Holding History

PAR Capital Management’s Portfolio ARLZ Stock Details ARLZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-481,400
Closed -$168K – 88
2018
Q2 		$168K Sell
481,400
-3,949,901
-89% -$3.24M ﹤0.01% 82
2018
Q1 		$6.65M Sell
4,431,301
-1,511,008
-25% -$2.64M 0.07% 71
2017
Q4 		$8.44M Sell
5,942,309
-457,691
-7% -$751K 0.09% 66
2017
Q3 		$14.7M Hold
6,400,000
– – 0.17% 55
2017
Q2 		$8.64M Hold
6,400,000
– – 0.1% 63
2017
Q1 		$13.7M Hold
6,400,000
– – 0.17% 54
2016
Q4 		$28.2M Hold
6,400,000
– – 0.37% 47
2016
Q3 		$31M Hold
6,400,000
– – 0.45% 44
2016
Q2 		$21.1M Buy
6,400,000
+1,035,000
+19% +$3.91M 0.35% 44
2016
Q1 		$19M Buy
+5,365,000
New +$27.7M 0.31% 50

Other funds holding ARLZ

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

PAR Capital Management's ARLZ Position: Q3 2018 in Review

PAR Capital Management sold out of Aralez Pharmaceuticals Inc. (ARLZ) in Q3 2018, closing a stake of 481,400 shares — an estimated $168K sold.

PAR Capital Management first reported a position in ARLZ in Q1 2016 and held it in 10 quarters. The position peaked at $31M in Q3 2016. 4 funds tracked by Wall St. Rank hold ARLZ as of Q3 2018.

  • PAR Capital Management reported no remaining Aralez Pharmaceuticals Inc. position as of Q3 2018 after selling out during the quarter.
  • PAR Capital Management sold 481,400 Aralez Pharmaceuticals Inc. shares in Q3 2018, an estimated $168K.
  • PAR Capital Management first reported a position in Aralez Pharmaceuticals Inc. in Q1 2016 and held it in 10 quarters.
  • PAR Capital Management's Aralez Pharmaceuticals Inc. position peaked at $31M in Q3 2016.
  • 4 funds tracked by Wall St. Rank held Aralez Pharmaceuticals Inc. as of Q3 2018.

Based on PAR Capital Management's 13F filing for Q3 2018, filed 14 Nov 2018.